Waters Redefines Laboratory Science with New ACQUITY PREMIER Liquid Chromatography Solution
February 10 2021 - 8:00AM
Business Wire
Company’s Most Significant Advance in
Chromatography Since UPLC Aims to Accelerate Scientific Research
and Development
News Summary:
- Mitigates loss of metal-sensitive analytes to yield higher
quality data with less time and effort
- Novel MaxPeak High Performance Surface technology eliminates
the need for system and column passivation and improves analytical
sensitivity and assay-to-assay reproducibility
- ACQUITY PREMIER system and column chemistries work together to
provide enhanced analytical data quality and greater confidence in
separation results
Waters Corporation (NYSE:WAT) today introduced the Waters™
ACQUITY™ PREMIER Solution, the next generation in liquid
chromatographs featuring Waters’ breakthrough MaxPeak™ High
Performance Surface (HPS) technology. The solution leverages HPS to
vastly improve analytical data quality and eliminate the need for
time-consuming and costly passivation.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210210005204/en/
The Waters ACQUITY PREMIER Solution
combines the power of the ACQUITY PREMIER System with ACQUITY
PREMIER Columns to improve detection sensitivity and assay-to-assay
reproducibility for chromatographic separations of metal-sensitive
analytes like organic acids, organophosphates, oligonucleotides,
phosphopeptides, acidic glycans and phospholipids. (Photo: Business
Wire)
ACQUITY PREMIER is a universal liquid chromatograph (LC)
solution that combines the ACQUITY PREMIER System with ACQUITY
PREMIER Columns with MaxPeak HPS technology. It is designed to
alleviate the problem of analyte/metal surface interactions when
analyzing organic acids, organophosphates, oligonucleotides,
phosphopeptides, acidic glycans and phospholipids by reversed phase
and hydrophilic interaction chromatography. For these analyses, the
new ACQUITY PREMIER solution cuts the time from sample to results,
improves analyte recovery and assay-to-assay reproducibility, to
give separation scientists greater assurance in the integrity of
their qualitative and quantitative analytical results.
“The ACQUITY PREMIER Solution represents our biggest innovation
in separation science since UPLC,” said Ian King, Senior Vice
President, Global Products, Waters Corporation. “Chromatography has
an immeasurable impact on the development of novel therapeutics and
treatments for innumerable diseases. The result of decades of
separations science know-how along with the combined efforts of our
materials scientists, chemists and engineers, ACQUITY PREMIER
addresses a long-standing problem that has held back scientific
progress long enough. We firmly believe it will redefine the value
that separations science brings to scientific achievement.”
MaxPeak High Performance Surface Technology
MaxPeak HPS technology is a hybrid organic/inorganic surface
technology that forms a barrier between the sample and the metal
surfaces of both the system and column. By mitigating, or
eliminating altogether, non-specific adsorption, the ACQUITY
PREMIER Solution offers many benefits, among them:
- increased analyte recovery with 10-100X improvement in
detectioni sensitivity for low-level phosphorylated and
carboxylated analytes reducing the risk of unseen analytes going
undetected
- sharper peak shapes and greater peak capacity for more accurate
analyte identification and data interpretation
- greater reproducibility for separations prone to adsorptive
losses meaning less re-work or troubleshooting, and more confidence
in results
- no more system passivation to waste valuable sample material or
tie up instrument cycles
- eases the transfer of methods from site-to-site and from
company-to-company
- offers UPLC performance for the analysis of both
metal-sensitive and non-metal-sensitive analytes making it a truly
universal liquid chromatography solution
“This approach solves a real problem with the analysis of some
particularly troublesome analytes,” said noted expert and
consultant Prof. Ian Wilson, Faculty of Medicine, Dept. of
Metabolism, Digestion and Reproduction, Imperial College London.
“The improvements in peak shape and signal-to-noise ratio at low
concentrations of analytes like phosphorylated drugs and lipids are
obvious at a glance and very impressive, and it will make the lives
of many analysts much easier.”
The ACQUITY PREMIER System and ACQUITY PREMIER columns are now
available worldwide from Waters.
Additional Resources
- Read our white paper: Low Adsorption UPLC Systems Based on
MaxPeak High Performance Surfaces: The ACQUITY PREMIER
Solution
- Learn more about the ACQUITY PREMIER Solution
- Join our February 10 ACQUITY PREMIER launch event or watch
on-demand
- Learn more about the ACQUITY PREMIER Solution for
oligonucleotides analysis
- Connect with Waters via LinkedIn, Twitter, and Facebook
About Waters Corporation (www.waters.com)
Waters Corporation (NYSE:WAT), the world's leading specialty
measurement company, has pioneered chromatography, mass
spectrometry, and thermal analysis innovations serving the life,
materials, and food sciences for more than 60 years. With more than
7,000 employees worldwide, Waters operates directly in 35
countries, including 15 manufacturing facilities, and with products
available in more than 100 countries.
Waters, ACQUITY and MaxPeak are trademarks of Waters
Corporation.
i Typical results based on Waters lab
tests of multiple compounds using both standard UPLC systems and
columns compared with ACQUITY PREMIER system and columns featuring
MaxPeak HPS. Detection sensitivity may vary depending on the
analytes being measured.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210210005204/en/
Brian J. Murphy PR Manager, Corporate Communications Waters
Corporation brian_j_murphy@waters.com +1 508-482-2614
Waters (NYSE:WAT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Waters (NYSE:WAT)
Historical Stock Chart
From Sep 2023 to Sep 2024